Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Giovanni Del Poeta, Maria Ilaria Del Principe, Luca Maurillo, Francesca Maria Rossi, Francesco Buccisano, Emanuele Ammatuna, Cristina Simotti, Antonella Zucchetto, Gianfranco Catalano, Pietro Bulian, Antonio Bruno, Adriano Venditti, Paolo De Fabritiis, Valter Gattei & Sergio Amadori. (2010) Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. Leukemia & Lymphoma 51:1, pages 95-106.
Read now
Read now
Jafri Malin Abdullah, Farizan Ahmad, Ku Asmarina Ku Ahmad, Mazira Mohamad Ghazali, Hasnan Jaafar, Aini Ideris, Abdul Manaf Ali, Abdul Rahman Omar, Khatijah Yusoff, Mohd Azmi Mohd Lila & Fauziah Othman. (2007) Molecular genetic analysis of BAX and cyclin D1 genes in patients with malignant glioma. Neurological Research 29:3, pages 239-242.
Read now
Read now
James B Johnston, James T Paul, Nathan J Neufeld, Neil Haney, Dianne M Kropp, Xiaojie Hu, Mary Cheang & Spencer B Gibson. (2004) Role of Myeloid Cell Factor-1 (Mcl-1) in Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 45:10, pages 2017-2027.
Read now
Read now
Alun Thomas, Chris Pepper, Terry Hoy & Paul Bentley. (2004) Bryostatin Induces Protein Kinase C Modulation, Mcl-1 Up-Regulation and Phosphorylation of Bcl-2 Resulting in Cellular Differentiation and Resistance to Drug-induced Apoptosis in B-cell Chronic Lymphocytic Leukemia Cells. Leukemia & Lymphoma 45:5, pages 997-1008.
Read now
Read now
Chris Pepper, Kerenza Hooper, Alun Thomas, Terry Hoy & Paul Bentley. (2001) Bcl-2 Antisense Oligonucleotides Enhance the Cytotoxicity of Chlorambucil in B-Cell Chronic Lymphocytic Leukaemia Cells. Leukemia & Lymphoma 42:3, pages 491-498.
Read now
Read now
Steven M Kornblau, Marina Konopleva & Michael Andreeff. (1999) Apoptosis regulating proteins as targets of therapy for haematological malignancies. Expert Opinion on Investigational Drugs 8:12, pages 2027-2057.
Read now
Read now
Articles from other publishers (77)
Mehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, Maliheh Entezari, Mahsa Mojtabavi, Behnaz Raei, Mohammad Arad Zandieh, Mitra Behroozaghdam, Sepideh Mirzaei, Kiavash Hushmandi, Noushin Nabavi, Shokooh Salimimoghadam, Jun Ren, Mohsen Rashidi, Rasoul Raesi, Afshin Taheriazam, Athanasios Alexiou, Marios Papadakis & Shing Cheng Tan. (2023) Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance. Cellular & Molecular Biology Letters 28:1.
Crossref
Crossref
Xiaoping Xie, Jiangbi Li, Feng Gu, Ke Zhang, Zilong Su, Qiangqiang Wen, Zhenjiang Sui, Pengcheng Zhou & Tiecheng Yu. (2021) Genetic Determinants for Bacterial Osteomyelitis: A Focused Systematic Review of Published Literature. Frontiers in Genetics 12.
Crossref
Crossref
Brigitte Bauvois, Elodie Pramil, Ludovic Jondreville, Claire Quiney, Florence Nguyen-Khac & Santos A. Susin. (2021) Activation of Interferon Signaling in Chronic Lymphocytic Leukemia Cells Contributes to Apoptosis Resistance via a JAK-Src/STAT3/Mcl-1 Signaling Pathway. Biomedicines 9:2, pages 188.
Crossref
Crossref
Rui Cai, Ping Wang, Xin Zhao, Xiansheng Lu, Ruxia Deng, Xiaoyu Wang, Zhaoji Su, Chang Hong & Jie Lin. (2020) LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation. Journal of Translational Medicine 18:1.
Crossref
Crossref
Anzana Parvin, Shuang-Li Hao, Fu-Qing Tan & Wan-Xi Yang. (2020) Inhibition of kinesin motor protein KIFC1 by AZ82 induces multipolar mitosis and apoptosis in prostate cancer cell. Gene 760, pages 144989.
Crossref
Crossref
Giovanni Del Poeta, Annalisa Biagi, Luca Laurenti, Annalisa Chiarenza, Federico Pozzo, Idanna Innocenti, Massimiliano Postorino, Francesca Maria Rossi, Maria Ilaria Del Principe, Riccardo Bomben, Paolo de Fabritiis, Antonio Bruno, Maria Cantonetti, Francesco Di Raimondo, Antonella Zucchetto & Valter Gattei. (2020) Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia. Haematologica 106:9, pages 2345-2353.
Crossref
Crossref
RihabMalik Rahid & MaysemMouayad Alwash. (2020) BAX/BCL2 ratio in chronic lymphocytic leukemia and its association with ZAP-70 expression and other clinicopathological parameters. Iraqi Journal of Hematology 9:1, pages 34.
Crossref
Crossref
Myoung-Schook Yoou, Sungjoon Cho & Youngjin Choi. (2019) Molecular Docking-assisted Protein Chip Screening of Inhibitors for Bcl-2 Family Protein-protein Interaction to Discover Anticancer Agents by Fragment-based Approach. BioChip Journal 13:3, pages 260-268.
Crossref
Crossref
Chris Fegan & Chris Pepper. (2019)
Is venetoclax a new wonder drug in
CLL
?
. British Journal of Haematology 185:4, pages 643-646.
Crossref
Crossref
Yixiang Chen, Chloé Peubez, Victoria Smith, Shiqiu Xiong, Gabriella Kocsis‐Fodor, Ben Kennedy, Simon Wagner, Constantine Balotis, Sandrine Jayne, Martin J. S. Dyer & Salvador Macip. (2018)
CUDC
‐907 blocks multiple pro‐survival signals and abrogates microenvironment protection in
CLL
. Journal of Cellular and Molecular Medicine 23:1, pages 340-348.
Crossref
Crossref
Nahla Mohamed Gamal Farahat, Dalal Mohamed Nasr El Din Elkaffash, Ashraf Hussein Alghandour, Rania Shafik Swelem & Reham Abdel Haleem Abo El-Wafa. (2018) Study of microRNA Profile as a Molecular Biomarker in Egyptian Chronic Lymphocytic Leukemia. Indian Journal of Hematology and Blood Transfusion 35:1, pages 89-99.
Crossref
Crossref
Annika Hantusch, Markus Rehm & Thomas Brunner. (2018) Counting on Death – Quantitative aspects of Bcl‐2 family regulation. The FEBS Journal 285:22, pages 4124-4138.
Crossref
Crossref
Kazuo Yamagata, Yuri Izawa, Daiki Onodera & Motoki Tagami. (2017) Chlorogenic acid regulates apoptosis and stem cell marker-related gene expression in A549 human lung cancer cells. Molecular and Cellular Biochemistry 441:1-2, pages 9-19.
Crossref
Crossref
Kai Cao & Stephen W.G. Tait. 2018.
135
152
.
Gudapureddy Radha & Sathees C. Raghavan. (2017) BCL2: A promising cancer therapeutic target. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:1, pages 309-314.
Crossref
Crossref
Kazuo Yamagata, Ayame Fujiwara, Daiki Onodera & Tagami Motoki. (2019) Lutein Regulates the Expression of Apoptosis-related Genes and Stem Cell Markers in A549 Human Lung Cancer Cells. Natural Product Communications 12:6, pages 1934578X1701200.
Crossref
Crossref
Ahmad Baraka, Shereen El Shorbagy, Ola M. Elfarargy, Rasha Haggag, Lobna A. Abdelaziz, Salah F. Elsayed & Khaled A. Elbana. (2017) Prognostic Significance of Apoptosis Regulators in B-Cell Chronic Lymphocytic Leukemia. Journal of Cancer Therapy 08:04, pages 360-385.
Crossref
Crossref
Bowen Ke, Mao Tian, Jingjing Li, Bo Liu & Gu He. (2016) Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy. Medicinal Research Reviews 36:6, pages 983-1035.
Crossref
Crossref
Lian Chen, Hengmin Cui, Jing Fang, Huidan Deng, Ping Kuang, Hongrui Guo, Xun Wang & Ling Zhao. (2016) Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells. Oncotarget 7:34, pages 54691-54701.
Crossref
Crossref
A R D Delbridge & A Strasser. (2015) The BCL-2 protein family, BH3-mimetics and cancer therapy. Cell Death & Differentiation 22:7, pages 1071-1080.
Crossref
Crossref
Noelia Purroy, Pau Abrisqueta, Júlia Carabia, Cecilia Carpio, Carles Palacio, Francesc Bosch & Marta Crespo. (2014)
Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating
in vivo
. Oncotarget 6:10, pages 7632-7643.
Crossref
Crossref
Emilio Cosimo, Alison M. McCaig, Luke J.M. Carter-Brzezinski, Helen Wheadon, Michael T. Leach, Karine Le Ster, Christian Berthou, Emilie Durieu, Nassima Oumata, Hervé Galons, Laurent Meijer & Alison M. Michie. (2013) Inhibition of NF-κB–Mediated Signaling by the Cyclin-Dependent Kinase Inhibitor CR8 Overcomes Prosurvival Stimuli to Induce Apoptosis in Chronic Lymphocytic Leukemia Cells. Clinical Cancer Research 19:9, pages 2393-2405.
Crossref
Crossref
Chris Fegan & Chris Pepper. 2013. Advances in Chronic Lymphocytic Leukemia. Advances in Chronic Lymphocytic Leukemia
151
171
.
Reza Ghassemifar, Luke Forster, Jill Finlayson, Tony Calogero, Brad Augustson, David Joske & Gavin Cull. (2012) Differential expression of the Bcl-2 and Bax isoforms in CD19 positive B-lymphocytes isolated from patients diagnosed with chronic lymphocytic leukaemia. Pathology 44:7, pages 632-637.
Crossref
Crossref
Flora Tzifi, Christina Economopoulou, Dimitrios Gourgiotis, Alexandros Ardavanis, Sotirios Papageorgiou & Andreas Scorilas. (2012) The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias. Advances in Hematology 2012, pages 1-15.
Crossref
Crossref
Sayer Al-harbiBrian T. HillSuparna MazumderKamini SinghJennifer DeVecchioGaurav Choudhary, Lisa A. Rybicki, Matt KalaycioJaroslaw P. Maciejewski, Janet A. HoughtonAlexandru Almasan. (2011) An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737. Blood 118:13, pages 3579-3590.
Crossref
Crossref
Sotirios G. PapageorgiouChristos K. Kontos, Vassiliki PappaHellinida Thomadaki, Frida KontsiotiJohn DervenoulasEfstathios PapageorgiouTheofanis EconomopoulosAndreas Scorilas. (2011)
The Novel Member of the
BCL2
Gene Family,
BCL2L12
, Is Substantially Elevated in Chronic Lymphocytic Leukemia Patients, Supporting Its Value As a Significant Biomarker
. The Oncologist 16:9, pages 1280-1291.
Crossref
Crossref
C Spagnuolo, C Cerella, M Russo, S Chateauvieux, M Diederich & G L Russo. (2011) Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. British Journal of Cancer 105:2, pages 221-230.
Crossref
Crossref
E Gross, F-E L’Faqihi-Olive, L Ysebaert, M Brassac, S Struski, S Kheirallah, J-J Fournié, G Laurent & A Quillet-Mary. (2010) B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells. Leukemia 24:11, pages 1885-1892.
Crossref
Crossref
Andrea G.S. Buggins, Chris Pepper, Piers E.M. Patten, Saman Hewamana, Satyen Gohil, Jane Moorhead, Najeem'deen Folarin, Deborah Yallop, N. Shaun B. Thomas, Ghulam J. Mufti, Chris Fegan & Stephen Devereux. (2010)
Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation and
De novo
Gene Transcription
. Cancer Research 70:19, pages 7523-7533.
Crossref
Crossref
Andrea G.S. Buggins & Chris J. Pepper. (2010) The role of Bcl-2 family proteins in chronic lymphocytic leukaemia. Leukemia Research 34:7, pages 837-842.
Crossref
Crossref
Petra Korać, Marija Gilming Vintar, Radmila Ajduković, Mirjana Mariana Kardum Paro, Branimir Jakšić & Mara Dominis. (2009) FOXP1 and BCL2 Show Similar Immunoenzymatic Pattern in Bone Marrow Trephines of Chronic Lymphocytic Leukemia Patients. Applied Immunohistochemistry & Molecular Morphology 17:6, pages 500-504.
Crossref
Crossref
Dorota Lemancewicz, Janusz Dziecioł, Jarosław Piszcz, Agnieszka Lebelt, Katarzyna Mazgajska-Barczyk, Beata Klim & Janusz Kłoczko. (2008) Assessment of expression of selected Bcl-2 family proteins in lymphoid infiltration in patients with B-cell chronic lymphocytic leukaemia treated with nucleoside analogues.. Folia Histochemica et Cytobiologica 46:3.
Crossref
Crossref
Chris PepperThet Thet LinGuy PrattSaman Hewamana, Paul Brennan, Louise Hiller, Robert HillsRachel WardJane StarczynskiBelinda AustenLaura HooperTatjana StankovicChris Fegan. (2008) Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood 112:9, pages 3807-3817.
Crossref
Crossref
A.M. MichieR. NakagawaA.M. McCaig. (2007) Murine models for chronic lymphocytic leukaemia. Biochemical Society Transactions 35:5, pages 1009-1012.
Crossref
Crossref
A Olsson, M Norberg, A ökvist, K Derkow, A Choudhury, G Tobin, F Celsing, A österborg, R Rosenquist, M Jondal & L M Osorio. (2007) Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. British Journal of Cancer 97:6, pages 769-777.
Crossref
Crossref
Marcos G Ocaña, Eulalia Valle-Garay, A Hugo Montes, Álvaro Meana, José antonio Cartón, Joshua Fierer, Antonio Celada & Víctor Asensi. (2007) Bax gene G(-248)A promoter polymorphism is associated with increased lifespan of the neutrophils of patients with osteomyelitis. Genetics in Medicine 9:4, pages 249-255.
Crossref
Crossref
Holger NückelUlrich H. FreyMaja BauLudger Sellmann, Jens Stanelle, Jan Dürig, Karl-Heinz Jöckel, Ulrich Dührsen & Winfried Siffert. (2006) Association of a novel regulatory polymorphism (−938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood 109:1, pages 290-297.
Crossref
Crossref
Rajani Korukonda, Na Guan, James T. Dalton, Jiuyu Liu & Isaac O. Donkor. (2006)
Synthesis, Calpain Inhibitory Activity, and Cytotoxicity of P
2
-Substituted Proline and Thiaproline Peptidyl Aldehydes and Peptidyl α-Ketoamides
. Journal of Medicinal Chemistry 49:17, pages 5282-5290.
Crossref
Crossref
Clare E. Dempsey, Darren L. Roberts & Caroline Dive. 2006. Apoptosis and Cancer Therapy. Apoptosis and Cancer Therapy
346
378
.
Øystein Bruserud, Karl Johan Tronstad, Emmet McCormack & Bjørn Tore Gjertsen. (2005) Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?. Cancer Immunology, Immunotherapy 55:2, pages 221-228.
Crossref
Crossref
Elena Monti. 2006. Cancer Drug Resistance. Cancer Drug Resistance
241
260
.
Kristina Jonas, Erhard Van Der Vries, Mikael T.I. Nilsson & Mikael Widersten. (2005) Isolation of novel single-chain Cro proteins targeted for binding to the bcl-2 transcription initiation site by repertoire selection and subunit combinatorics. Protein Engineering, Design and Selection 18:11, pages 537-546.
Crossref
Crossref
Kumudha Balakrishnan, William G. Wierda, Michael J. Keating & Varsha Gandhi. (2005) Mechanisms of Cell Death of Chronic Lymphocytic Leukemia Lymphocytes by RNA-Directed Agent, 8-NH2-Adenosine. Clinical Cancer Research 11:18, pages 6745-6752.
Crossref
Crossref
Jane Starczynski, Chris Pepper, Guy Pratt, Laura Hooper, Alun Thomas, Donald Milligan, Paul Bentley & Christopher Fegan. (2005)
Common Polymorphism G(-248)A in the Promoter Region of the
bax
Gene Results in Significantly Shorter Survival in Patients With Chronic Lymphocytic Leukemia Once Treatment Is Initiated
. Journal of Clinical Oncology 23:7, pages 1514-1521.
Crossref
Crossref
Alejo A. Morales, Anna Olsson, Fredrik Celsing, Anders Österborg, Mikael Jondal & Lyda M. Osorio. (2005) High expression of Bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia. International Journal of Cancer 113:5, pages 730-737.
Crossref
Crossref
Alexey V. Danilov, Andreas K. Klein, Henry J. Lee, Diana Velez Baez & Brigitte T. Huber. (2005)
Differential control of G
0
programme in chronic lymphocytic leukaemia: a novel prognostic factor
. British Journal of Haematology 128:4, pages 472-481.
Crossref
Crossref
Sanjeev Shangary, Christopher L. Oliver & Daniel E. Johnson. 2005. Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases. Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases
107
135
.
Vladimir Kirkin, Stefan Joos & Martin Zörnig. (2004) The role of Bcl-2 family members in tumorigenesis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1644:2-3, pages 229-249.
Crossref
Crossref
H.P Monteiro, E.F Silva & A Stern. (2004) Nitric oxide: a potential inducer of adhesion-related apoptosis—anoikis. Nitric Oxide 10:1, pages 1-10.
Crossref
Crossref
A A Morales, A Olsson, F Celsing, A Österborg, M Jondal & L M Osorio. (2003) Expression and transcriptional regulation of functionally distinct Bmf isoforms in B-chronic lymphocytic leukemia cells. Leukemia 18:1, pages 41-47.
Crossref
Crossref
Vonda K. Douglas & Raul C. Braylan. 2004. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
145
161
.
Anurag Saxena, Sathiyanarayanan Viswanathan, Oksana Moshynska, Puneeta Tandon, Koravangattu Sankaran & David P. Sheridan. (2003) Mcl‐1 and Bcl‐2/Bax ratio are associated with treatment response but not with Rai stage in B‐cell chronic lymphocytic leukemia. American Journal of Hematology 75:1, pages 22-33.
Crossref
Crossref
R T Snowden, X-M Sun, M J S Dyer & G M Cohen. (2003) Bisindolylmaleimide IX is a potent inducer of apoptosis in chronic lymphocytic leukaemic cells and activates cleavage of Mcl-1. Leukemia 17:10, pages 1981-1989.
Crossref
Crossref
Gabriele AnetherInge TinhoferMonika SenfterRichard Greil. (2003) Tetrocarcin-A—induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2—independent pathway. Blood 101:11, pages 4561-4568.
Crossref
Crossref
Grant Dewson, Roger T Snowden, Jason B Almond, Martin J S Dyer & Gerald M Cohen. (2003) Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells. Oncogene 22:17, pages 2643-2654.
Crossref
Crossref
Thierry Vincent, Laurence Molina, Lucile Espert & Nadir Mechti. (2003) Hyaluronan, a major non-protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma. British Journal of Haematology 121:2, pages 259-269.
Crossref
Crossref
S Salvioli, G Storci, M Pinti, D Quaglino, L Moretti, M Merlo-Pich, G Lenaz, S Filosa, A Fico, M Bonafè, D Monti, L Troiano, M Nasi, A Cossarizza & C Franceschi. (2003) Apoptosis-resistant phenotype in HL-60-derived cells HCW-2 is related to changes in expression of stress-induced proteins that impact on redox status and mitochondrial metabolism. Cell Death & Differentiation 10:2, pages 163-174.
Crossref
Crossref
Anurag Saxena, Oksana Moshynska, Koravangattu Sankaran, Sathiyanarayanan Viswanathan & David P Sheridan. (2002) Association of a novel single nucleotide polymorphism, G(−248)A, in the 5′-UTR of BAX gene in chronic lymphocytic leukemia with disease progression and treatment resistance. Cancer Letters 187:1-2, pages 199-205.
Crossref
Crossref
Chris PepperKhalida AliAlun ThomasTerry Hoy, Chris Fegan, Pratima Chowdary, Jonathan Kell & Paul Bentley. (2002) Retinoid‐induced apoptosis in B‐cell chronic lymphocytic leukaemia cells is mediated through caspase‐3 activation and is independent of p53, the retinoic acid receptor, and differentiation. European Journal of Haematology 69:4, pages 227-235.
Crossref
Crossref
Jacek M. WitkowskiEmilia Zmuda-TrzebiatowskaJakub M. SwierczMiroslawa CichorekHanna CiepluchKrzysztof LewandowskiEwa BrylAndrzej Hellmann. (2002) Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood 100:5, pages 1802-1809.
Crossref
Crossref
Shinichi Kitada, Irene M Pedersen, Aaron D Schimmer & John C Reed. (2002) Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene 21:21, pages 3459-3474.
Crossref
Crossref
RW Craig. (2002) MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 16:4, pages 444-454.
Crossref
Crossref
John C. ByrdShinichi KitadaIan W. FlinnJennifer L. AronMichael PearsonDavid LucasJohn C. Reed. (2002) The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood 99:3, pages 1038-1043.
Crossref
Crossref
T Liu, E Raetz, PJ Moos, SL Perkins, CS Bruggers, F Smith & WL Carroll. (2002) Diversity of the apoptotic response to chemotherapy in childhood leukemia. Leukemia 16:2, pages 223-232.
Crossref
Crossref
B Siegmund, J Welsch, F Loher, G Meinhardt, B Emmerich, S Endres & A Eigler. (2001) Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis. Leukemia 15:10, pages 1564-1571.
Crossref
Crossref
N R Monks, D C Blakey, N J Curtin, S J East, A Heuze & D R Newell. (2001) Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue. British Journal of Cancer 85:5, pages 764-771.
Crossref
Crossref
Neil E. Kay, Lei Han, Nancy Bone & Gary Williams. (2001)
Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8
+
T cells from B‐CLL patients: impact on clonal B‐cell apoptosis
. British Journal of Haematology 112:3, pages 760-767.
Crossref
Crossref
Wieslawa H. Dragowska, Daniel E. Lopes de Menezes, Jason Sartor & Lawrence D. Mayer. (2000) Quantitative fluorescence cytometric analysis of Bcl-2 levels in tumor cells exhibiting a wide range of inherent Bcl-2 protein expression: Correlation with Western blot analysis. Cytometry 40:4, pages 346-352.
Crossref
Crossref
Shinichi KitadaJuan M. ZapataMichael AndreeffJohn C. Reed. (2000) Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia. Blood 96:2, pages 393-397.
Crossref
Crossref
Gang‐Ming Zou, Marie‐Françoise Reznikoff‐Etievant, François Hirsch & Jacques Milliez. (2001) IFN‐γ induces apoptosis in mouse embryonic stem cells, a putative mechanism of its embryotoxicity. Development, Growth & Differentiation 42:3, pages 257-264.
Crossref
Crossref
Gang Li, Jason A. Bush & Vincent C. Ho. (2000) p53-Dependent Apoptosis in Melanoma Cells After Treatment with Camptothecin 1. Journal of Investigative Dermatology 114:3, pages 514-519.
Crossref
Crossref
Inge Tinhofer, PhD, Ingrid Marschitz, MD, Marion Kos, Richard Greil, MD, Anton Hittmair, MD & Alexander Egle, MD. (2000) Analysis of Bcl-2 Protein Expression in Chronic Lymphocytic Leukemia. American Journal of Clinical Pathology 113:2, pages 219-229.
Crossref
Crossref
Rajat Bannerji & John C. Byrd. (2000) Update on the biology of chronic lymphocytic leukemia. Current Opinion in Oncology 12:1, pages 22-29.
Crossref
Crossref
Viengthong Lam, J.Peter McPherson, Leonardo Salmena, Jodi Lees, William Chu, Elizabeth Sexsmith, David W Hedley, Melvin H Freedman, John C Reed, David Malkin & Gerald J Goldenberg. (1999) p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin. Leukemia Research 23:10, pages 871-880.
Crossref
Crossref
John C. Reed. (1999) Dysregulation of Apoptosis in Cancer. Journal of Clinical Oncology 17:9, pages 2941-2941.
Crossref
Crossref
Jacques Gardais. (1999) Is there still a place for clinical staging in chronic lymphocytic leukaemia?. Leukemia Research 23:6, pages 589-592.
Crossref
Crossref